“…In particular, it seems to be is a promising candidate to treat diseases such as diabetes (Ussher et al, 2011; Kurek et al, 2017) retinitis pigmentosa (Piano et al, 2013;Strettoi et al, 2010), cystic fibrosis (Caretti et al, 2014;Caretti et al, 2016) and myocardial infarction (Reforgiato et al, 2016). Myriocin is active at few nanomoles dose (1-5 microg) as a powerful immunosuppressant, and may have clinical potential in organ transplantation and for the treatment of autoimmune diseases (Fujita et al, 1994).…”